Acoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failure

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to Acoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failure
(NASDAQ: BBIO) Delayed: 68.63 -0.29 (0.42%)
Previous Close $68.92    52 Week High $ 
Open $68.57    52 Week Low $ 
Day High $69.90    P/E N/A 
Day Low $68.03    EPS $ 
Volume 2,454,753